Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News
First in vivo validation of KLRG1 as a new cancer immunotherapy target

Related or similar articles

October 9, 2024

Explore Labshares' Latest High-Tech Equipment Advancements

Labshares News
March 13, 2019

Labshares Celebrates Grand Opening and Unveils Newly Expanded Shared Office and Lab Space in Newton

Labshares Newton's newly expanded facility features a cutting-edge lab and co-working space that can now accommodate up to 30 startups
Press Releases
October 9, 2024

A Fresh New Look at Labshares: Office Upgrade at 90 Bridge Street

Labshares News